Quantcast

Latest Teva Pharmaceutical Industries Stories

2014-03-30 23:21:43

Texas Medicaid fraud attorney J. Mark Brewer says he hopes $27 million payments by Teva Pharmaceutical Industries Ltd. to resolve allegations of illegal payments to a doctor to prescribe certain drugs sends a strong message to other drug companies. Houston, TX (PRWEB) March 30, 2014 Teva Pharmaceutical Industries Ltd. recently agreed to pay the federal government and the State of Illinois $27.6 million to resolve allegations of illegally paying a doctor to prescribe certain dangerous...

2014-02-12 12:30:26

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Brazilian Pharmaceutical Market 2014-2024Report DetailsDrug selling in Brazil - this new analysis shows you trends, opportunities, and revenuesDo you want to assess the future of pharmaceuticals in Brazil? See what lies ahead, then. Visiongain's new report gives you revenue predictions, helping your work. There you discover financial results, trends, opportunities, and sales forecasts.So...

2014-01-30 12:27:36

CHICAGO, Jan. 30, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Teva Pharmaceutical Industries Limited (NYSE:TEVA-Free Report), Novartis (NYSE:NVS-Free Report), Biogen Idec (Nasdaq:BIIB-Free Report), Actavis (NYSE:ACT-Free Report) and VimpelCom Limited (Nasdaq:VIP-Free...

2014-01-28 08:37:54

CHICAGO, Jan. 28, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Hanesbrands Inc. (NYSE:HBI-Free Report), Teva Pharmaceutical Industries Limited (NYSE:TEVA-Free Report), Novartis (NYSE:NVS-Free Report), Biogen Idec (Nasdaq:BIIB-Free Report) and Actavis (NYSE:ACT-Free...

2014-01-27 16:24:30

WILMINGTON, Del., Jan. 27, 2014 /PRNewswire/ -- Rigrodsky & Long, P.A.: -- Do you, or did you, own shares of Teva Pharmaceutical Industries Limited (NYSE: TEVA)? -- Did you purchase your shares between January 1, 2012 and October 29, 2013, inclusive? -- Did you lose money in your investment in Teva Pharmaceutical Industries Limited? -- Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it has filed a class action...

2014-01-15 08:31:01

NEW YORK, January 15, 2014 /PRNewswire/ -- BreedIT Corp (OTC: BRDT), through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding solutions for plant breeders and researchers, today announced that on January 7, 2014, the Company's board of directors appointed chemistry and pharmaceutical industry expert Dr. Ben-Zion Weiner as its new member of the board. From 1975 to 2012, Dr. Weiner held executive positions...

2014-01-10 08:23:41

Leadership Appointment Bolsters API Business and Leadership Team ALBANY, N.Y., Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position of Managing Director, AMRI India, effective January 2, 2014. Mr. Batra will report to Steve Hagen, Ph.D., Senior Vice President of Manufacturing and Pharmaceuticals. "Mr. Batra brings a wealth of experience in the Active Pharmaceutical Ingredients (APIs) and...

2014-01-08 08:28:37

HERZLIYA, Israel, January 8, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) (TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced it has signed a licensing agreement with Yeda Research and Development Company Ltd. ("Yeda") to develop hCDR1, a Phase II-ready asset for the treatment of...

2013-11-12 23:24:43

Reportbuyer.com just published a new market research report: Pharma Contract Manufacturing: World Market Outlook 2013-2023. London (PRWEB) November 12, 2013 Report Details Contracted drug production - discover trends and segments with highest revenue potential Where's outsourced pharma manufacturing heading? Visiongain's updated report predicts that industry's revenues from 2013. There you find potentials for sales growth, also understanding trends, technologies for drugs,...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related